Skip to main content

Meeting the Global Demand for Iron-Based Therapies

A new CSL Vifor manufacturing facility in St. Gallen, Switzerland, has a modular design that can be expanded – cube by cube – to meet future needs.

Story

ST. GALLEN, SWITZERLAND - CSL Vifor, a leader in iron-based therapies, recently opened Multicube, a state-of-the-art manufacturing facility that will help meet the increasing global demand for iron-based therapies needed to treat iron deficiency and iron deficiency anemia.

The new facility in St. Gallen increases CSL Vifor’s ability to produce the active pharmaceutical ingredient (API) in its iron products – and the building has an innovative design. The facility can be expanded by adding additional “cubes” when future capacity is needed. Multicube was also designed with sustainability in mind.

“The Multicube project is not only increasing the current active pharmaceutical ingredient (API) production capacity for our iron products but also has a sustainability focus. With the newest technologies, we will be able to recover the heat created during our production with condensate collectors and reuse it to heat the whole manufacturing site, providing possible energy savings and emissions benefits," said Abdullah Karakoc, Team Leader Project Engineering.

Additionally, a photovoltaic system will enable the site to produce some of the electricity it needs, thereby reducing reliance on purchased electricity.

Watch the video to learn more from Manuel Senn, St. Gallen’s Site Head.